ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure

ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure

ZnO nanoparticles (ZnONPs) have been shown to have therapeutic potential in some diseases such as diabetes and cancer. However, concentration-dependent adverse effects have also been reported. Studies which evaluate the effects of ZnONPs on the cardiovascular system are scarce. This study aimed to e...

Full description

Bibliographic Details
Main Authors: Adriana Ceballos-Gutiérrez, Alejandrina Rodríguez-Hernández, María del Rosario Álvarez-Valadez, Saraí Limón-Miranda, Felipa Andrade, Alejandro Figueroa-Gutiérrez, Irene Díaz-Reval, Alejandro Apolinar-Iribe, Luis Castro-Sánchez, Javier Alamilla, Enrique Sánchez-Pastor, Adolfo Virgen-Ortiz
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Nanomaterials
Subjects:
ZnO nanoparticles
dyslipidemia
cardiovascular
atherosclerosis
vascular contractility
blood pressure
Online Access:https://www.mdpi.com/2079-4991/11/9/2319

Internet

https://www.mdpi.com/2079-4991/11/9/2319

Similar Items